Operates a network of testing laboratories and inspection services across India, comprising 10 owned labs and 6 public-private partnership (PPP) labs. Service lines include pharmaceutical testing (including a USFDA-approved facility in Bengaluru), food testing (with a Mumbai laboratory), water and wastewater analysis, ethanol and process chemical testing, and inspection of mining, metals, machinery, electrical equipment, transport and water-supply infrastructure. NABCB accreditation under ISO/IEC 17020:2012 as a Type A Inspection Body enables inspection work in coal, railways, defense, automotive, electronics and government projects. The footprint has been built partly through acquisitions: Interstellar Testing Centre is now a wholly-owned subsidiary, Quality & Testing Infosolution was bought at 100%, LabOps Global at 74%, and a Mumbai food testing laboratory was acquired for Rs 882 Lakh. FY26 consolidated revenue was Rs 124.5 Cr, up 77% from FY25. Employee cost is the largest operating expense at 35.9% of revenue, followed by other opex at 27.1% and materials at 13.4%. A Rs 63 Cr capex plan is in place for FY27 to fund new labs in Gandhidham, Panipat and Bengaluru and new capabilities including EMI/EMC and analytical testing. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Laboratory testing services, Inspection services, Inspection assignments (post-NABCB accreditation), Lab operation and management contracts. Asset-light testing, inspection and certification (TIC) services, scaled through acquisitions.
| ₹ crore · consolidated | FY25 | FY26 |
|---|---|---|
| Revenue | 70 | 125 |
| EBITDA (ex other income) | — | — |
| margin % | — | — |
| Owners' profit | — | — |
| EPS, as reported (₹) | 7.08 | 13.38 |
| ROE % · ROCE % | — · 10.0 | — · 10.8 |
| Debt / equity (x) | — | — |
| Cash from operations | 10 | 15 |
| Capex | (23) | (12) |
| ₹ crore | Q4 FY25 | Q2 FY26 | Q4 FY26 |
|---|---|---|---|
| Revenue | 0 | 54 | 70 |
| Profit before tax | 0 | 6 | 12 |
| Net profit | — | — | — |
| EPS (₹) | 0.00 | 4.69 | 8.69 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| CENTRAL MINE P N D INST L | 15,301 | 50.3 | 6.70 | — | 26.9 | 34.6 | — | 34.9 |
| IIRM HOLDINGS INDIA LIMITED | 966 | 39.4 | 6.13 | 16.3 | 15.5 | 14.4 | — | 24.9 |
| Qualitek Labs Limited ◆ | 647 | 41.5 | — | — | — | 8.5 | — | — |
| Monarch Surveyors and Engineer | 411 | 8.4 | — | — | — | 20.9 | — | — |
| Ekansh Concepts Limited | 308 | 46.9 | 6.78 | 182.6 | (6.7) | (6.8) | (12.2) | 48.8 |
| LIKHAMI CONSULTING LIMITED | 297 | 934.1 | 8.46 | — | 0.7 | 0.9 | — | 67.2 |
| EKI ENERGY SERVICES LTD | 189 | 11.0 | 0.49 | 19.1 | (4.3) | (3.0) | — | (6.1) |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 7 Sept 2026 · Qualitek Labs withdraws director pay hike proposal from AGM agenda | board shareholder meetings | medium | — | — |
| 7 Sept 2026 · Qualitek Labs Withdraws Director Pay Hike Item from AGM Agenda | management changes | medium | — | — |
| 4 Sept 2026 · Newspaper Publication of 8th AGM Notice and E-Voting Details | compliance | minimal | — | — |
| 3 Sept 2026 · Qualitek Labs 8th AGM notice and FY26 Integrated Annual Report filed | board shareholder meetings | medium | — | — |
| 3 Sept 2026 · 8th AGM on Sep 25, 2026: FY26 results adoption, director re-appointment, RPT approval | board shareholder meetings | low | — | — |
| 29 Aug 2026 · Qualitek Labs 8th AGM on 25 Sep 2026, e-voting from 22 Sep | board shareholder meetings | low | — | — |
| 29 Aug 2026 · Board approves AGM notice, director re-appointment, higher managerial pay limit | board shareholder meetings | low | — | — |
| 29 Aug 2026 · Qualitek Labs board approves AGM notice, director re-appointment, higher pay limit | board shareholder meetings | low | — | — |
| 30 Jul 2026 · Company Secretary Mohit Kumar resigns from Qualitek Labs | management changes | medium | — | — |
| 10 Jul 2026 · Routine compliance filing: Reg 74(5) certificate for Q1 FY27 | compliance | minimal | — | — |
| Where a broker report shows | This document shows | Why |
|---|
| MITCON CON & ENG SER LTD | 139 | 12.7 | 0.81 | 6.7 | 5.4 | 5.1 | — | 12.7 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 41.5 | 8.4 | 21 of 25 | 17% |
| ROCE | 8.5 | 7.9 | 13 of 27 | 54% |
| Market cap | 647 | 37 | 3 of 26 | 92% |
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
